News & Event

Register for news & events
Loading
News background
News icon

2020

Tel Aviv Medical Center is recruiting Age related Macular Degeneration patients for a REVITALVISION clinical study

A Proof-of-Concept, Prospective, Open label, Randomized Clinical Study Evaluating RevitalVision® Therapy for Improving Best Corrected Visual Acuity (BCVA) and Contrast Sensitivity Function (CSF) in Patients Suffering from stabler Age related Macular Degeneration (AMD)

Age related Macular Degeneration

Contact Us

Talshir Medical Technologies LTD
Hama’ayan Street 2, Modi’in 7177871, Israel
USA Phone: +1.785.856.0417 | Main Office: +972.77.212.3272

info@revitalvision.com
Contact background